Bioxel files patent application for manufacturing paclitaxel, docetaxel APIs (PharmaBiz)
Bioxel files patent application for manufacturing paclitaxel, docetaxel APIs (PharmaBiz)
Bioxel Pharma Inc., a leading manufacturer and supplier of taxane active pharmaceutical ingredients (APIs) and developer of targeted oncology has filed a new patent covering the manufacturing of paclitaxel and docetaxel APIs by semi-synthesis.